MDB Capital Holdings, LLC (NASDAQ:MDBH) Short Interest Down 38.0% in February

MDB Capital Holdings, LLC (NASDAQ:MDBH) saw a large drop in short interest in the month of February. As of February 27th, there was short interest totaling 1,099 shares, a drop of 38.0% from the February 12th total of 1,772 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily volume of 3,828 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily volume of 3,828 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the company’s shares are short sold.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in MDBH. Raymond James Financial Inc. acquired a new position in shares of MDB Capital during the second quarter worth about $27,000. DRW Securities LLC acquired a new stake in shares of MDB Capital in the fourth quarter valued at about $40,000. Finally, Citadel Advisors LLC acquired a new stake in shares of MDB Capital in the third quarter valued at about $43,000. 0.35% of the stock is owned by hedge funds and other institutional investors.

MDB Capital Stock Down 4.5%

Shares of MDBH stock traded down $0.13 during mid-day trading on Friday, reaching $2.69. The company’s stock had a trading volume of 2,912 shares, compared to its average volume of 6,015. The firm has a market capitalization of $27.31 million, a PE ratio of 3.03 and a beta of 1.04. The company’s 50 day simple moving average is $3.26 and its 200-day simple moving average is $3.45. MDB Capital has a 12-month low of $2.80 and a 12-month high of $6.60.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of MDB Capital in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

About MDB Capital

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.